BioCentury
ARTICLE | Finance

Boehringer Ingelheim, UCB venture arms seed hearing loss newco Rinri

Disease-modifying data convinced Boehringer Ingelheim Venture Fund to co-lead the seed round for U.K. stem cell hearing loss company Rinri

May 20, 2019 6:08 AM UTC


Access this Article